Patents by Inventor Cecil Pace-Asciak

Cecil Pace-Asciak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF PREPARING A COMPOSITION FOR TREATING CANCER
    Publication number: 20200281989
    Abstract: A method of preparing a composition for treating cancer can include collecting epidermal gel secretions of catfish, extracting the total lipid fraction from the freeze-dried epidermal gel secretions to provide a total lipid fraction including neutral lipids, glycolipids, and phospholipids. A neutral lipid fraction, a glycolipid fraction, and a phospholipid fraction can then be separated from the total lipid fraction. Each of the total lipid fraction, the neutral lipid fraction, the glycolipid fraction, and the phospholipid fraction can exhibit anti-inflammatory and/or anti-cancer activities.
    Type: Application
    Filed: March 4, 2020
    Publication date: September 10, 2020
    Inventors: JASSIM M. HASSAN M. ALI, PEIYING YANG, CECIL PACE-ASCIAK
  • Hepodxilin analog enantiomers
    Patent number: 8710252
    Abstract: The present invention relates to enantiomeric forms of hepoxilin analogs of Formula I-VIII, pharmaceutical compositions thereof, a method for the separation of said enantiomeric forms of hepoxilin analogs comprising applying said hepoxilin to a chiral phase HPLC column and eluting said hepoxilin with an alkane and alcohol solvent mixture. Said enantiomeric forms of hepoxilin analogs of Formula I-VIII were found to be useful in controlling the biological effects of PPAR mediated transcriptional control for the treatment of diseases such as cancer, thromboxane-mediated diseases and for modulating intracellular calcium concentration.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: April 29, 2014
    Inventors: Cecil Pace-Asciak, Alexandra SantAna Sorensen, Jean-Philippe Meyer, Peter Denim
  • HEPOXILIN ANALOG ENANTIOMERS
    Publication number: 20100210727
    Abstract: The present invention relates to enantiomeric forms of hepoxilin analogs of Formula I-VIII, pharmaceutical compositions thereof, a method for the separation of said enantiomeric forms of hepoxilin analogs comprising applying said hepoxilin to a chiral phase HPLC column and eluting said hepoxilin with an alkane and alcohol solvent mixture. Said enantiomeric forms of hepoxilin analogs of Formula I-VIII were found to be useful in controlling the biological effects of PPAR mediated transcriptional control for the treatment of diseases such as cancer, thromboxane-mediated diseases and for modulating intracellular calcium concentration.
    Type: Application
    Filed: April 19, 2007
    Publication date: August 19, 2010
    Applicant: EVOLVA S.A.
    Inventors: Cecil Pace-Asciak, Alexandra SantAna Sorensen, Jean-Philippe Meyer, Peter Demin
  • Compositions comprising hepoxilin analogs and their use in the treatment of cancer
    Patent number: 7666905
    Abstract: Methods and pharmaceutical compositions comprise at least one hepoxilin analog of the formula (I) wherein X and R3 are as defined herein. The methods are directed to treatment of a cancer and for promotion of a apoptosis in a cancer cell.
    Type: Grant
    Filed: November 29, 2004
    Date of Patent: February 23, 2010
    Inventor: Cecil Pace-Asciak
  • Compositions comprising hepoxilin analogs and their use in the treatment of cancer
    Publication number: 20050272671
    Abstract: Methods and pharmaceutical compositions comprise at least one hepoxilin analog of the formula (I) wherein X and R3 are as defined herein. The methods are directed to treatment of a cancer and for promotion of a apoptosis in a cancer cell.
    Type: Application
    Filed: November 29, 2004
    Publication date: December 8, 2005
    Inventor: Cecil Pace-Asciak